Sanofi-Aventis, a pharmaceutical company headquartered in France, has awarded Euro RSCG Life the global advertising account for the thrombosis treatment Lovenox and for Lantus and Apidra diabetes
treatment. The assignment includes advertising, medical education, public relations, medical DTC and interactive in 60 countries including the 12 major worldwide markets. Spending was not disclosed.